HRMY Stock Summary and Trading Ideas (Harmony Biosciences Hldgs | NASDAQ:HRMY)

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Harmony Biosciences Hldgs trades on the NASDAQ stock market under the symbol HRMY.

As of September 11, 2026, HRMY stock price climbed to $41.52 with 892,452 million shares trading.

HRMY has a beta of 0.60, meaning it tends to be less sensitive to market movements. HRMY has a correlation of 0.03 to the broad based SPY ETF.

HRMY has a market cap of $2.42 billion. This is considered a Mid Cap stock.

Last quarter Harmony Biosciences Hldgs reported $261 million in Revenue and $1.28 earnings per share. This beat revenue expectation by $19 million and exceeded earnings estimates by $.23.

In the last 3 years, HRMY traded as high as $43.49 and as low as $18.61.

The top ETF exchange traded funds that HRMY belongs to (by Net Assets): AVUV, VTI, VB, FESM, VBK.

HRMY has outperformed the market in the last year with a price return of +24.2% while the SPY ETF gained +17.4%. HRMY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +18.0% and +5.9%, respectively, while the SPY returned +3.9% and -0.7%, respectively.

HRMY support price is $40.15 and resistance is $42.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HRMY shares will trade within this expected range on the day.